Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, posted on LinkedIn:
“What an amazing opening session at ASCO25, focused on case-based panel discussion on whether ctDNA can guide treatment/management of colorectal cancer.”
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, posted on LinkedIn:
“What an amazing opening session at ASCO25, focused on case-based panel discussion on whether ctDNA can guide treatment/management of colorectal cancer.”
